Rama Elluru

Rama G. Elluru is currently a Senior Director at the Special Competitive Studies Project (SCSP), a non-profit, funded by Eric and Wendy Schmidt and established to make recommendations to strengthen America’s long-term competitiveness for a future where artificial intelligence (AI) and other emerging technologies reshape our national security, economy, and society.  Previous to the SCSP, she was a Director at the National Security Commission on Artificial Intelligence (NSCAI), an independent Commission established by Congress to consider the methods and means to advance the development of AI, ML, and associated technologies to address the national security and defense needs of the United States.  She was detailed to the NSCAI from the United States Patent and Trademark Office (USPTO), where she served as an Administrative Patent Judge on the Patent Trial and Appeal.  Before joining the USPTO, Rama practiced IP law for 20 years, particularly in analyzing and litigating E.E. and bio-pharma patents. She graduated from Trinity University with a B.S. in Computer Science/Philosophy and obtained a J.D. from the Washington and Lee School of Law. After law school, she received a M.S. in Biochemistry/Molecular Biology from Georgetown University.

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More

If Private Sector R&D Is the Future, IP Policy Must Catch Up

By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely
Read More